| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.768 | 0.002 | 0.768 | Tyrosine 3 hydroxylase inhibitor | 0.388 0.009 DBMET03097 | ||
| 0.671 | 0.002 | 0.671 | Phenylalanine 4-hydroxylase inhibitor | 0.436 0.003 DBMET03097 | ||
| 0.673 | 0.017 | 0.673 | Cyclophilin D inhibitor | 0.519 0.045 DBMET03097 | ||
| 0.583 | 0.003 | 0.583 | 5 Hydroxytryptamine uptake stimulant | 0.483 0.005 DBMET03097 | ||
| 0.581 | 0.005 | 0.581 | Peroxidase inhibitor | 0.431 0.016 DBMET03097 | ||
| 0.554 | 0.009 | 0.554 | Superoxide dismutase inhibitor | 0.441 0.02 DBMET03097 | ||
| 0.507 | 0.003 | 0.507 | Histidine decarboxylase inhibitor | 0.272 0.008 DBMET03097 | ||
| 0.503 | 0.001 | 0.503 | DOPA decarboxylase inhibitor | 0.273 0.003 DBMET03097 | ||
| 0.51 | 0.026 | 0.707 | 5 Hydroxytryptamine release stimulant | 0.707 0.007 DBMET03097 | DBMET03097 | |
| 0.467 | 0.003 | 0.467 | Glutamate decarboxylase inhibitor | 0.304 0.004 DBMET03097 | ||
| 0.46 | 0.019 | 0.46 | Hypoglycemic | 0.344 0.039 DBMET03097 | ||
| 0.422 | 0.021 | 0.422 | Interleukin 2 agonist | 0.318 0.062 DBMET03097 | ||
| 0.414 | 0.017 | 0.414 | Interleukin agonist | 0.299 0.048 DBMET03097 | ||
| 0.433 | 0.059 | 0.433 | 5 Hydroxytryptamine release inhibitor | 0.306 0.158 DBMET03097 | ||
| 0.418 | 0.046 | 0.418 | Cholesterol antagonist | 0.217 0.15 DBMET03097 | ||
| 0.374 | 0.006 | 0.428 | GABA C receptor agonist | 0.428 0.005 DBMET03097 | DBMET03097 | |
| 0.397 | 0.029 | 0.397 | Antiamyloidogenic | 0.283 0.057 DBMET03097 | ||
| 0.372 | 0.013 | 0.372 | Phospholipase C inhibitor | 0.332 0.016 DBMET03097 | ||
| 0.357 | 0.003 | 0.357 | Glutamate (mGluR group III) agonist | 0.042 0.031 DBMET03097 | ||
| 0.358 | 0.004 | 0.358 | Catalase inhibitor | 0.084 0.045 DBMET03097 | ||
| 0.379 | 0.026 | 0.379 | Psychostimulant | 0.237 0.063 DBMET03097 | ||
| 0.353 | 0.002 | 0.353 | Glutamate (mGluR3) antagonist | 0.067 0.007 DBMET03097 | ||
| 0.352 | 0.005 | 0.423 | Nitric-oxide synthase stimulant | 0.423 0.003 DBMET03097 | DBMET03097 | |
| 0.345 | 0.007 | 0.345 | Cystathionine beta-synthase inhibitor | 0.172 0.032 DBMET03097 | ||
| 0.368 | 0.035 | 0.368 | Free radical scavenger | 0.352 0.038 DBMET03097 | ||
| 0.322 | 0.01 | 0.322 | Insulin secretagoues | 0.217 0.028 DBMET03097 | ||
| 0.345 | 0.034 | 0.345 | Angiogenesis stimulant | 0.214 0.087 DBMET03097 | ||
| 0.312 | 0.005 | 0.312 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.123 0.038 DBMET03097 | ||
| 0.337 | 0.039 | 0.337 | Insulysin inhibitor | 0.286 0.067 DBMET03097 | ||
| 0.306 | 0.023 | 0.306 | Thrombolytic | 0.157 0.077 DBMET03097 | ||
| 0.413 | 0.131 | 0.413 | Antiinflammatory | 0.329 0.189 DBMET03097 | ||
| 0.292 | 0.011 | 0.292 | Cell adhesion inhibitor | |||
| 0.346 | 0.065 | 0.346 | Immunostimulant | 0.182 0.132 DBMET03097 | ||
| 0.341 | 0.063 | 0.341 | Immunomodulator | |||
| 0.275 | 0.008 | 0.275 | NMDA receptor antagonist | 0.237 0.01 DBMET03097 | ||
| 0.344 | 0.079 | 0.344 | Transcription factor NF kappa B inhibitor | 0.287 0.102 DBMET03097 | ||
| 0.274 | 0.01 | 0.274 | Aminopeptidase B inhibitor | 0.151 0.037 DBMET03097 | ||
| 0.279 | 0.02 | 0.279 | Monophenol monooxygenase inhibitor | 0.158 0.044 DBMET03097 | ||
| 0.28 | 0.021 | 0.28 | Insulin sensitizer | 0.201 0.072 DBMET03097 | ||
| 0.315 | 0.056 | 0.315 | Antioxidant | 0.293 0.064 DBMET03097 | ||
| 0.263 | 0.007 | 0.263 | Glutamate dehydrogenase inhibitor | 0.098 0.032 DBMET03097 | ||
| 0.298 | 0.044 | 0.298 | DNA synthesis inhibitor | 0.224 0.09 DBMET03097 | ||
| 0.315 | 0.062 | 0.333 | Aldehyde oxidase inhibitor | 0.333 0.058 DBMET03097 | DBMET03097 | |
| 0.269 | 0.019 | 0.294 | Hemostatic | 0.294 0.016 DBMET03097 | DBMET03097 | |
| 0.261 | 0.014 | 0.261 | Glutamate receptor antagonist | 0.111 0.084 DBMET03097 | ||
| 0.252 | 0.007 | 0.252 | Glutamate receptor agonist | 0.069 0.064 DBMET03097 | ||
| 0.263 | 0.021 | 0.263 | Alpha-N-acetylglucosaminidase inhibitor | 0.139 0.062 DBMET03097 | ||
| 0.277 | 0.037 | 0.277 | Growth hormone agonist | 0.14 0.095 DBMET03097 | ||
| 0.313 | 0.077 | 0.313 | Apoptosis antagonist | 0.246 0.131 DBMET03097 | ||
| 0.286 | 0.051 | 0.286 | Pyruvate kinase inhibitor | |||
| 0.236 | 0.006 | 0.236 | Argininosuccinate synthase inhibitor | 0.054 0.042 DBMET03097 | ||
| 0.239 | 0.011 | 0.239 | Toll-Like receptor 2 antagonist | 0.208 0.02 DBMET03097 | ||
| 0.286 | 0.058 | 0.286 | Platelet antagonist | |||
| 0.247 | 0.022 | 0.247 | Neurotensin receptor agonist | 0.18 0.05 DBMET03097 | ||
| 0.263 | 0.045 | 0.263 | Anesthetic general | 0.215 0.067 DBMET03097 | ||
| 0.234 | 0.016 | 0.234 | Ferrochelatase inhibitor | 0.198 0.023 DBMET03097 | ||
| 0.246 | 0.029 | 0.246 | Amylase inhibitor | 0.154 0.062 DBMET03097 | ||
| 0.219 | 0.006 | 0.219 | Inducible nitric-oxide synthase inhibitor | 0.206 0.008 DBMET03097 | ||
| 0.212 | 0.004 | 0.212 | AMPA 2 receptor antagonist | |||
| 0.234 | 0.028 | 0.234 | Succinate dehydrogenase inhibitor | 0.201 0.048 DBMET03097 | ||
| 0.214 | 0.008 | 0.214 | NMDA 2 receptor antagonist | 0.202 0.009 DBMET03097 | ||
| 0.253 | 0.049 | 0.265 | Peptidyltransferase inhibitor | 0.265 0.041 DBMET03097 | DBMET03097 | |
| 0.31 | 0.109 | 0.31 | Immunosuppressant | 0.218 0.178 DBMET03097 | ||
| 0.293 | 0.093 | 0.293 | Antithrombotic | |||
| 0.314 | 0.116 | 0.314 | Histamine release inhibitor | 0.208 0.193 DBMET03097 | ||
| 0.313 | 0.126 | 0.353 | Antibacterial | 0.353 0.1 DBMET03097 | DBMET03097 | |
| 0.189 | 0.003 | 0.189 | Glutamate (mGluR6) antagonist | 0.076 0.029 DBMET03097 | ||
| 0.194 | 0.009 | 0.194 | Keratolytic | 0.115 0.023 DBMET03097 | ||
| 0.194 | 0.01 | 0.194 | Prolactin inhibitor | 0.134 0.029 DBMET03097 | ||
| 0.237 | 0.054 | 0.237 | Platelet adhesion inhibitor | |||
| 0.186 | 0.005 | 0.186 | Glutamate (mGluR7) agonist | 0.14 0.016 DBMET03097 | ||
| 0.201 | 0.021 | 0.201 | Farnesoid X receptor antagonist | |||
| 0.18 | 0.003 | 0.18 | Glutamate (mGluR1) agonist | |||
| 0.188 | 0.011 | 0.2 | Nitric-oxide synthase inhibitor | 0.2 0.009 DBMET03097 | DBMET03097 | |
| 0.187 | 0.01 | 0.187 | Cell adhesion molecule inhibitor | |||
| 0.19 | 0.014 | 0.19 | HIV-1 integrase (Overall Integration) inhibitor | 0.172 0.018 DBMET03097 | ||
| 0.179 | 0.003 | 0.179 | AMPA 3 receptor antagonist | 0.037 0.016 DBMET03097 | ||
| 0.334 | 0.159 | 0.446 | Caspase 9 stimulant | 0.446 0.085 DBMET03097 | DBMET03097 | |
| 0.187 | 0.013 | 0.2 | Creatine kinase inhibitor | 0.2 0.01 DBMET03097 | DBMET03097 | |
| 0.19 | 0.016 | 0.19 | Sphingosine 1-phosphate receptor 5 antagonist | 0.173 0.031 DBMET03097 | ||
| 0.191 | 0.018 | 0.237 | Adenylate cyclase stimulant | 0.237 0.005 DBMET03097 | DBMET03097 | |
| 0.225 | 0.052 | 0.225 | Hepatoprotectant | 0.142 0.119 DBMET03097 | ||
| 0.205 | 0.039 | 0.205 | Interferon gamma antagonist | 0.143 0.088 DBMET03097 | ||
| 0.183 | 0.018 | 0.183 | Mucolytic | 0.107 0.068 DBMET03097 | ||
| 0.165 | 0.002 | 0.165 | Glutamate (mGluR8) agonist | 0.061 0.007 DBMET03097 | ||
| 0.169 | 0.009 | 0.169 | Carbonic anhydrase stimulant | 0.103 0.018 DBMET03097 | ||
| 0.168 | 0.01 | 0.168 | Aminopeptidase I inhibitor | 0.084 0.039 DBMET03097 | ||
| 0.166 | 0.01 | 0.166 | Carbamoyl phosphate synthetase inhibitor | 0.068 0.036 DBMET03097 | ||
| 0.162 | 0.009 | 0.345 | Myeloperoxidase inhibitor | 0.345 0.003 DBMET03097 | DBMET03097 | |
| 0.181 | 0.028 | 0.181 | Chelator | 0.145 0.037 DBMET03097 | ||
| 0.197 | 0.044 | 0.197 | Phospholipase A2 inhibitor | 0.153 0.072 DBMET03097 | ||
| 0.202 | 0.052 | 0.202 | Anticoagulant | |||
| 0.168 | 0.021 | 0.168 | Adenylate kinase inhibitor | 0.114 0.049 DBMET03097 | ||
| 0.163 | 0.017 | 0.163 | Alcohol dehydrogenase inhibitor | 0.117 0.037 DBMET03097 | ||
| 0.148 | 0.004 | 0.148 | AMPA 4 receptor antagonist | 0.039 0.029 DBMET03097 | ||
| 0.211 | 0.067 | 0.217 | Neurotrophic factor enhancer | 0.217 0.062 DBMET03097 | DBMET03097 | |
| 0.171 | 0.028 | 0.171 | Expectorant | |||
| 0.167 | 0.024 | 0.173 | Sphingosine 1-phosphate receptor 2 antagonist | 0.173 0.019 DBMET03097 | DBMET03097 | |
| 0.157 | 0.017 | 0.157 | Aminoacyl-tRNA synthetase inhibitor | 0.082 0.073 DBMET03097 | ||
| 0.187 | 0.047 | 0.187 | Lipid peroxidase inhibitor | 0.117 0.097 DBMET03097 | ||
| 0.141 | 0.002 | 0.141 | Kainate receptor agonist | 0.042 0.027 DBMET03097 | ||
| 0.146 | 0.008 | 0.147 | GABA aminotransferase inhibitor | 0.147 0.008 DBMET03097 | DBMET03097 | |
| 0.164 | 0.027 | 0.164 | Vanilloid 1 agonist | 0.159 0.03 DBMET03097 | ||
| 0.154 | 0.017 | 0.154 | Phosphofructokinase-1 inhibitor | 0.073 0.045 DBMET03097 | ||
| 0.145 | 0.009 | 0.145 | NMDA receptor agonist | 0.063 0.043 DBMET03097 | ||
| 0.177 | 0.041 | 0.177 | Histone deacetylase SIRT1 inhibitor | 0.165 0.05 DBMET03097 | ||
| 0.149 | 0.014 | 0.149 | Glutamate (mGluR) agonist | |||
| 0.19 | 0.056 | 0.209 | Antipruritic | 0.209 0.043 DBMET03097 | DBMET03097 | |
| 0.139 | 0.006 | 0.259 | 5 Hydroxytryptamine 2A agonist | 0.259 0.003 DBMET03097 | DBMET03097 | |
| 0.143 | 0.011 | 0.143 | Integrin antagonist | |||
| 0.16 | 0.028 | 0.16 | Interleukin 8 antagonist | 0.124 0.056 DBMET03097 | ||
| 0.133 | 0.002 | 0.133 | Tryptophan hydroxylase 1 inhibitor | |||
| 0.182 | 0.05 | 0.182 | Melanin inhibitor | 0.17 0.059 DBMET03097 | ||
| 0.16 | 0.028 | 0.16 | Heat shock protein 70 antagonist | 0.152 0.042 DBMET03097 | ||
| 0.166 | 0.036 | 0.222 | Adenylate cyclase inhibitor | 0.222 0.022 DBMET03097 | DBMET03097 | |
| 0.173 | 0.045 | 0.173 | Cell wall synthesis inhibitor | 0.172 0.045 DBMET03097 | ||
| 0.231 | 0.103 | 0.231 | Gastrin inhibitor | |||
| 0.132 | 0.005 | 0.132 | Kainate receptor antagonist | |||
| 0.135 | 0.009 | 0.135 | Glycine transporter 2 inhibitor | 0.065 0.023 DBMET03097 | ||
| 0.14 | 0.014 | 0.14 | Ornithine decarboxylase inhibitor | 0.115 0.03 DBMET03097 | ||
| 0.132 | 0.008 | 0.132 | NMDA receptor subunit 3B antagonist | |||
| 0.18 | 0.056 | 0.18 | Protein-tyrosine phosphatase inhibitor | |||
| 0.128 | 0.004 | 0.128 | Glutamate (mGluR group III) antagonist | |||
| 0.128 | 0.004 | 0.128 | Glutamate (mGluR7) antagonist | 0.066 0.051 DBMET03097 | ||
| 0.131 | 0.011 | 0.131 | Ornithine carbamoyltransferase inhibitor | 0.054 0.036 DBMET03097 | ||
| 0.12 | 0.003 | 0.12 | Glutamate (mGluR1a) agonist | 0.022 0.016 DBMET03097 | ||
| 0.158 | 0.042 | 0.158 | Cyclooxygenase 3 inhibitor | 0.129 0.067 DBMET03097 | ||
| 0.2 | 0.084 | 0.2 | Interleukin antagonist | 0.163 0.109 DBMET03097 | ||
| 0.123 | 0.006 | 0.123 | NMDA receptor subunit 3A antagonist | |||
| 0.149 | 0.034 | 0.149 | Nav1.4 sodium channel blocker | 0.12 0.052 DBMET03097 | ||
| 0.195 | 0.081 | 0.234 | Amyloid beta aggregation inhibitor | 0.234 0.063 DBMET03097 | DBMET03097 | |
| 0.191 | 0.079 | 0.191 | Non-steroidal antiinflammatory agent | 0.175 0.091 DBMET03097 | ||
| 0.116 | 0.005 | 0.116 | Integrin alpha4 antagonist | |||
| 0.217 | 0.107 | 0.269 | Spasmolytic | 0.269 0.083 DBMET03097 | DBMET03097 | |
| 0.114 | 0.004 | 0.114 | Kainate receptor 2 antagonist | |||
| 0.142 | 0.032 | 0.174 | Carbonic anhydrase III inhibitor | 0.174 0.021 DBMET03097 | DBMET03097 | |
| 0.118 | 0.008 | 0.137 | GABA B receptor agonist | 0.137 0.005 DBMET03097 | DBMET03097 | |
| 0.144 | 0.035 | 0.144 | Photosensitizer | 0.121 0.055 DBMET03097 | ||
| 0.133 | 0.024 | 0.179 | Porphobilinogen synthase inhibitor | 0.179 0.015 DBMET03097 | DBMET03097 | |
| 0.113 | 0.005 | 0.113 | VLA-4 antagonist | |||
| 0.112 | 0.005 | 0.112 | AMPA 1 receptor antagonist | |||
| 0.109 | 0.002 | 0.109 | Tryptophan 5 hydroxylase inhibitor | 0.039 0.017 DBMET03097 | ||
| 0.245 | 0.14 | 0.27 | Vasodilator, coronary | 0.27 0.115 DBMET03097 | DBMET03097 | |
| 0.135 | 0.03 | 0.135 | Toll-Like receptor 4 antagonist | 0.134 0.031 DBMET03097 | ||
| 0.107 | 0.002 | 0.107 | Glutamate (mGluR3) agonist | 0.036 0.014 DBMET03097 | ||
| 0.15 | 0.046 | 0.15 | Cathepsin H inhibitor | |||
| 0.13 | 0.027 | 0.13 | Triose-phosphate isomerase inhibitor | 0.107 0.041 DBMET03097 | ||
| 0.27 | 0.166 | 0.27 | Analgesic | 0.227 0.206 DBMET03097 | ||
| 0.108 | 0.005 | 0.108 | Glutamate (mGluR4) antagonist | |||
| 0.107 | 0.004 | 0.107 | Dipeptidyl peptidase I inhibitor | 0.099 0.004 DBMET03097 | ||
| 0.105 | 0.004 | 0.105 | Glutamate (mGluR4) agonist | |||
| 0.249 | 0.149 | 0.249 | Toll-Like receptor agonist | |||
| 0.167 | 0.068 | 0.167 | Arachidonic acid antagonist | 0.161 0.075 DBMET03097 | ||
| 0.117 | 0.02 | 0.135 | Vanilloid agonist | 0.135 0.013 DBMET03097 | DBMET03097 | |
| 0.116 | 0.018 | 0.116 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.159 | 0.062 | 0.159 | Thiol protease inhibitor | 0.131 0.094 DBMET03097 | ||
| 0.112 | 0.015 | 0.112 | Glycine receptor agonist | 0.089 0.029 DBMET03097 | ||
| 0.119 | 0.023 | 0.119 | Glutathione S-transferase inhibitor | |||
| 0.111 | 0.015 | 0.111 | Antimetabolite | |||
| 0.151 | 0.058 | 0.151 | Bone formation stimulant | |||
| 0.096 | 0.003 | 0.096 | AMPA receptor agonist | |||
| 0.244 | 0.153 | 0.244 | Toll-Like receptor 7 agonist | |||
| 0.111 | 0.019 | 0.111 | HIV-1 integrase inhibitor | 0.1 0.025 DBMET03097 | ||
| 0.142 | 0.052 | 0.155 | Aldehyde dehydrogenase inhibitor | 0.155 0.045 DBMET03097 | DBMET03097 | |
| 0.106 | 0.018 | 0.106 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.089 | 0.002 | 0.089 | Glutamate (mGluR6) agonist | 0.011 0.01 DBMET03097 | ||
| 0.151 | 0.064 | 0.151 | Mannose-6-phosphate isomerase inhibitor | 0.126 0.091 DBMET03097 | ||
| 0.105 | 0.02 | 0.105 | Ribonucleotide reductase inhibitor | |||
| 0.088 | 0.003 | 0.088 | Glutamate (mGluR8) antagonist | 0.037 0.021 DBMET03097 | ||
| 0.112 | 0.028 | 0.112 | Bile acid receptor antagonist | |||
| 0.112 | 0.027 | 0.112 | Opioid delta receptor antagonist | |||
| 0.122 | 0.038 | 0.122 | Folate antagonist | |||
| 0.088 | 0.005 | 0.088 | Arginase inhibitor | 0.055 0.012 DBMET03097 | ||
| 0.088 | 0.005 | 0.088 | Glutamate (mGluR group II) antagonist | |||
| 0.133 | 0.054 | 0.133 | Protein-tyrosine phosphatase 1B inhibitor | |||
| 0.177 | 0.098 | 0.303 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.303 0.023 DBMET03097 | DBMET03097 | |
| 0.097 | 0.019 | 0.125 | Alcohol oxidase inhibitor | 0.125 0.013 DBMET03097 | DBMET03097 | |
| 0.082 | 0.004 | 0.082 | Kainate receptor 1 antagonist | |||
| 0.229 | 0.152 | 0.229 | Sodium/bile acid cotransporter inhibitor | |||
| 0.094 | 0.018 | 0.094 | NMDA 2C receptor antagonist | 0.077 0.027 DBMET03097 | ||
| 0.078 | 0.004 | 0.078 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.076 0.004 DBMET03097 | ||
| 0.172 | 0.099 | 0.172 | DNA methylase inhibitor | |||
| 0.106 | 0.033 | 0.188 | Adrenaline agonist | 0.188 0.008 DBMET03097 | DBMET03097 | |
| 0.193 | 0.12 | 0.193 | Calpain inhibitor | |||
| 0.103 | 0.032 | 0.103 | Cathepsin G inhibitor | |||
| 0.139 | 0.068 | 0.139 | Alkaline phosphatase inhibitor | |||
| 0.074 | 0.003 | 0.074 | Thyroid hormone agonist | 0.025 0.019 DBMET03097 | ||
| 0.095 | 0.025 | 0.095 | Glucagon-like peptide 1 agonist | |||
| 0.114 | 0.045 | 0.114 | Anabolic | 0.108 0.052 DBMET03097 | ||
| 0.203 | 0.134 | 0.253 | Transcription factor STAT inhibitor | 0.253 0.085 DBMET03097 | DBMET03097 | |
| 0.085 | 0.018 | 0.085 | NMDA 2A receptor antagonist | 0.053 0.034 DBMET03097 | ||
| 0.079 | 0.012 | 0.079 | Alpha-mannosidase inhibitor | 0.071 0.016 DBMET03097 | ||
| 0.082 | 0.016 | 0.082 | Phosphorylase inhibitor | |||
| 0.086 | 0.022 | 0.086 | Aminopeptidase microsomal inhibitor | |||
| 0.189 | 0.125 | 0.189 | DNA damaging | 0.18 0.134 DBMET03097 | ||
| 0.091 | 0.027 | 0.091 | Sirtuin 1 inhibitor | 0.081 0.035 DBMET03097 | ||
| 0.126 | 0.062 | 0.165 | Beta amyloid protein antagonist | 0.165 0.031 DBMET03097 | DBMET03097 | |
| 0.235 | 0.171 | 0.235 | Antiobesity | |||
| 0.121 | 0.058 | 0.121 | Caspase 3 inhibitor | |||
| 0.08 | 0.017 | 0.08 | Botulinum neurotoxin type A inhibitor | 0.08 0.017 DBMET03097 | ||
| 0.107 | 0.045 | 0.167 | Lanosterol 14 alpha demethylase inhibitor | 0.167 0.007 DBMET03097 | DBMET03097 | |
| 0.117 | 0.055 | 0.196 | GABA C receptor antagonist | 0.196 0.014 DBMET03097 | DBMET03097 | |
| 0.157 | 0.097 | 0.157 | DNA methyltransferase I inhibitor | |||
| 0.193 | 0.133 | 0.195 | Neuropeptide Y2 antagonist | 0.195 0.128 DBMET03097 | DBMET03097 | |
| 0.104 | 0.045 | 0.104 | Opioid antagonist | |||
| 0.11 | 0.051 | 0.11 | Factor V inhibitor | |||
| 0.196 | 0.139 | 0.209 | Transcription factor STAT3 inhibitor | 0.209 0.122 DBMET03097 | DBMET03097 | |
| 0.138 | 0.081 | 0.139 | Ca2+-transporting ATPase inhibitor | 0.139 0.076 DBMET03097 | DBMET03097 | |
| 0.099 | 0.043 | 0.11 | Glutamate release inhibitor | 0.11 0.03 DBMET03097 | DBMET03097 | |
| 0.094 | 0.039 | 0.158 | Macrophage migration inhibitory factor inhibitor | 0.158 0.013 DBMET03097 | DBMET03097 | |
| 0.064 | 0.009 | 0.064 | Fumarate hydratase inhibitor | |||
| 0.065 | 0.01 | 0.065 | Carbonic anhydrase I stimulant | 0.048 0.017 DBMET03097 | ||
| 0.123 | 0.069 | 0.33 | M18 aspartyl aminopeptidase inhibitor | 0.33 0.009 DBMET03097 | DBMET03097 | |
| 0.111 | 0.058 | 0.142 | AMP-activated protein kinase stimulant | 0.142 0.034 DBMET03097 | DBMET03097 | |
| 0.182 | 0.129 | 0.203 | RNA-directed DNA polymerase inhibitor | 0.203 0.095 DBMET03097 | DBMET03097 | |
| 0.061 | 0.009 | 0.061 | Prostacyclin antagonist | |||
| 0.065 | 0.014 | 0.065 | Mannosidase inhibitor | 0.064 0.014 DBMET03097 | ||
| 0.068 | 0.017 | 0.068 | Adenine nucleotide translocase inhibitor | |||
| 0.063 | 0.013 | 0.063 | AICAR transformylase inhibitor | 0.048 0.025 DBMET03097 | ||
| 0.089 | 0.039 | 0.089 | Analgesic, opioid | |||
| 0.067 | 0.018 | 0.067 | Glutamate (mGluR group I) agonist | |||
| 0.068 | 0.019 | 0.068 | Aconitate hydratase inhibitor | 0.053 0.035 DBMET03097 | ||
| 0.069 | 0.02 | 0.092 | Beta 2 adrenoreceptor agonist | 0.092 0.005 DBMET03097 | DBMET03097 | |
| 0.126 | 0.077 | 0.144 | Interleukin 4 antagonist | 0.144 0.055 DBMET03097 | DBMET03097 | |
| 0.054 | 0.006 | 0.054 | Kainate receptor 4 antagonist | |||
| 0.114 | 0.068 | 0.114 | Microtubule formation inhibitor | |||
| 0.066 | 0.019 | 0.066 | Complement C3a chemotactic receptor antagonist | |||
| 0.167 | 0.121 | 0.167 | Hypolipemic | |||
| 0.058 | 0.013 | 0.206 | Dopamine D5 agonist | 0.206 0.002 DBMET03097 | DBMET03097 | |
| 0.084 | 0.038 | 0.084 | Opioid mu receptor antagonist | |||
| 0.048 | 0.005 | 0.048 | Integrin alpha4beta7 antagonist | |||
| 0.049 | 0.005 | 0.049 | Kainate receptor 5 antagonist | |||
| 0.164 | 0.121 | 0.243 | Histone acetyltransferase inhibitor | 0.243 0.028 DBMET03097 | DBMET03097 | |
| 0.078 | 0.035 | 0.078 | HIV-1 integrase (3'-Processing) inhibitor | 0.062 0.045 DBMET03097 | ||
| 0.091 | 0.048 | 0.091 | Hematopoietic | |||
| 0.079 | 0.036 | 0.079 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.062 | 0.02 | 0.062 | Toll-Like receptor 2 agonist | |||
| 0.051 | 0.009 | 0.051 | VCAM-1 antagonist | |||
| 0.051 | 0.009 | 0.051 | VCAM antagonist | |||
| 0.149 | 0.107 | 0.149 | Lipocortins synthesis antagonist | |||
| 0.05 | 0.009 | 0.05 | Catechol O-methyltransferase inhibitor | 0.046 0.01 DBMET03097 | ||
| 0.064 | 0.023 | 0.064 | Aminopeptidase N inhibitor | |||
| 0.115 | 0.074 | 0.115 | Histone deacetylase class III inhibitor | |||
| 0.068 | 0.027 | 0.068 | Prolactin release inhibitor | |||
| 0.093 | 0.053 | 0.095 | NADH dehydrogenase inhibitor | 0.095 0.05 DBMET03097 | DBMET03097 | |
| 0.062 | 0.024 | 0.062 | AMPA receptor antagonist | |||
| 0.113 | 0.075 | 0.113 | Alkylator | |||
| 0.063 | 0.025 | 0.07 | Pregnane X receptor antagonist | 0.07 0.014 DBMET03097 | DBMET03097 | |
| 0.077 | 0.04 | 0.077 | Secretase beta inhibitor | |||
| 0.061 | 0.024 | 0.061 | Dipeptidyl peptidase inhibitor | 0.056 0.031 DBMET03097 | ||
| 0.078 | 0.042 | 0.078 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.125 | 0.088 | 0.179 | Protein kinase stimulant | 0.179 0.051 DBMET03097 | DBMET03097 | |
| 0.051 | 0.015 | 0.051 | Glutamate (mGluR group II) agonist | |||
| 0.086 | 0.05 | 0.229 | Carbonic anhydrase VI inhibitor | 0.229 0.01 DBMET03097 | DBMET03097 | |
| 0.206 | 0.17 | 0.206 | Vasodilator, peripheral | |||
| 0.14 | 0.105 | 0.141 | Nitric oxide antagonist | 0.141 0.103 DBMET03097 | DBMET03097 | |
| 0.056 | 0.021 | 0.056 | Thymidylate synthase inhibitor | |||
| 0.131 | 0.096 | 0.136 | NOS3 expression enhancer | 0.136 0.089 DBMET03097 | DBMET03097 | |
| 0.068 | 0.034 | 0.068 | Biliverdin reductase inhibitor | 0.055 0.047 DBMET03097 | ||
| 0.062 | 0.028 | 0.062 | Angiotensin-converting enzyme inhibitor | |||
| 0.11 | 0.076 | 0.121 | DNA polymerase I inhibitor | 0.121 0.067 DBMET03097 | DBMET03097 | |
| 0.051 | 0.019 | 0.051 | Dipeptidyl peptidase IV inhibitor | 0.042 0.037 DBMET03097 | ||
| 0.086 | 0.054 | 0.094 | D-Ala-D-Ala ligase inhibitor | 0.094 0.037 DBMET03097 | DBMET03097 | |
| 0.057 | 0.025 | 0.057 | Opioid mu receptor agonist | |||
| 0.041 | 0.01 | 0.041 | Lysine carboxypeptidase inhibitor | |||
| 0.087 | 0.057 | 0.087 | Granulocyte macrophage colony stimulating factor agonist | 0.083 0.066 DBMET03097 | ||
| 0.035 | 0.005 | 0.035 | Kainate receptor 3 antagonist | |||
| 0.063 | 0.033 | 0.063 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.05 | 0.02 | 0.05 | Leukotriene A4 hydrolase inhibitor | 0.038 0.026 DBMET03097 | ||
| 0.138 | 0.109 | 0.138 | Interleukin 6 antagonist | |||
| 0.053 | 0.024 | 0.134 | Dopamine beta hydroxylase inhibitor | 0.134 0.003 DBMET03097 | DBMET03097 | |
| 0.08 | 0.051 | 0.084 | Somatostatin 1 agonist | 0.084 0.047 DBMET03097 | DBMET03097 | |
| 0.032 | 0.004 | 0.032 | Thyroid hormone alpha agonist | |||
| 0.032 | 0.005 | 0.032 | Dipeptidyl peptidase IX inhibitor | 0.022 0.008 DBMET03097 | ||
| 0.052 | 0.027 | 0.052 | Neurotensin receptor antagonist | |||
| 0.054 | 0.029 | 0.054 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.041 | 0.015 | 0.041 | Free fatty acid receptor 1 antagonist | 0.03 0.029 DBMET03097 | ||
| 0.055 | 0.03 | 0.082 | Beta 2 adrenoreceptor antagonist | 0.082 0.011 DBMET03097 | DBMET03097 | |
| 0.068 | 0.044 | 0.068 | Selectin antagonist | |||
| 0.096 | 0.072 | 0.289 | Carbonic anhydrase XV inhibitor | 0.289 0.009 DBMET03097 | DBMET03097 | |
| 0.053 | 0.029 | 0.053 | CD45 antagonist | |||
| 0.055 | 0.031 | 0.075 | Vanilloid 2 antagonist | 0.075 0.011 DBMET03097 | DBMET03097 | |
| 0.061 | 0.038 | 0.067 | Sphingosine kinase inhibitor | 0.067 0.029 DBMET03097 | DBMET03097 | |
| 0.038 | 0.015 | 0.043 | Dipeptidyl peptidase II inhibitor | 0.043 0.012 DBMET03097 | DBMET03097 | |
| 0.058 | 0.035 | 0.058 | Leukotriene C antagonist | 0.053 0.052 DBMET03097 | ||
| 0.047 | 0.024 | 0.062 | Beta adrenoreceptor agonist | 0.062 0.007 DBMET03097 | DBMET03097 | |
| 0.083 | 0.06 | 0.083 | Factor XII inhibitor | |||
| 0.03 | 0.009 | 0.03 | Integrin beta7 antagonist | |||
| 0.091 | 0.07 | 0.091 | Xanthine oxidase inhibitor | |||
| 0.05 | 0.03 | 0.05 | Endothelin-converting enzyme inhibitor | |||
| 0.045 | 0.026 | 0.045 | Sphingosine 1-phosphate receptor 1 agonist | 0.044 0.026 DBMET03097 | ||
| 0.047 | 0.028 | 0.047 | Sphingosine 1-phosphate receptor agonist | 0.045 0.03 DBMET03097 | ||
| 0.061 | 0.041 | 0.061 | HIV-1 integrase (Strand Transfer) inhibitor | |||
| 0.078 | 0.06 | 0.078 | Glycine receptor antagonist | |||
| 0.054 | 0.036 | 0.054 | Aldose reductase inhibitor | |||
| 0.041 | 0.023 | 0.072 | 5 Hydroxytryptamine 2B agonist | 0.072 0.005 DBMET03097 | DBMET03097 | |
| 0.042 | 0.026 | 0.042 | Integrin alpha5beta1 antagonist | |||
| 0.028 | 0.012 | 0.028 | Vanilloid 2 agonist | 0.028 0.013 DBMET03097 | ||
| 0.101 | 0.085 | 0.111 | Cholesterol synthesis inhibitor | 0.111 0.074 DBMET03097 | DBMET03097 | |
| 0.052 | 0.036 | 0.062 | Carbonic anhydrase II stimulant | 0.062 0.021 DBMET03097 | DBMET03097 | |
| 0.148 | 0.132 | 0.148 | Anticonvulsant | 0.147 0.133 DBMET03097 | ||
| 0.055 | 0.039 | 0.08 | Sphingosine kinase 2 inhibitor | 0.08 0.015 DBMET03097 | DBMET03097 | |
| 0.24 | 0.225 | 0.24 | Apoptosis agonist | |||
| 0.041 | 0.026 | 0.041 | Membrane dipeptidase inhibitor | |||
| 0.06 | 0.045 | 0.06 | NMDA receptor glycine site agonist | |||
| 0.106 | 0.091 | 0.158 | Transcription factor STAT6 inhibitor | 0.158 0.018 DBMET03097 | DBMET03097 | |
| 0.041 | 0.028 | 0.041 | Erythropoietin receptor agonist | |||
| 0.033 | 0.02 | 0.033 | HCV NS5B polymerase inhibitor | |||
| 0.035 | 0.022 | 0.035 | Calcitonin receptor agonist | |||
| 0.06 | 0.047 | 0.06 | Trypsin inhibitor | 0.059 0.051 DBMET03097 | ||
| 0.047 | 0.035 | 0.047 | Glucose-6-phosphate isomerase inhibitor | |||
| 0.048 | 0.036 | 0.048 | Bombesin 2 receptor antagonist | |||
| 0.019 | 0.007 | 0.019 | Dipeptidyl peptidase VIII inhibitor | 0.014 0.012 DBMET03097 | ||
| 0.038 | 0.026 | 0.038 | Integrin alpha1beta1 antagonist | |||
| 0.051 | 0.039 | 0.051 | Opioid agonist | |||
| 0.037 | 0.026 | 0.112 | Kinesin-like protein 1 inhibitor | 0.112 0.006 DBMET03097 | DBMET03097 | |
| 0.037 | 0.026 | 0.112 | Kinesin antagonist | 0.112 0.006 DBMET03097 | DBMET03097 | |
| 0.03 | 0.019 | 0.03 | Glutamate (mGluR2) antagonist | |||
| 0.019 | 0.008 | 0.019 | Thyroid hormone alpha antagonist | |||
| 0.015 | 0.004 | 0.015 | Thyroid hormone beta agonist | |||
| 0.024 | 0.014 | 0.024 | ICAM 1 antagonist | |||
| 0.031 | 0.021 | 0.031 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.034 | 0.025 | 0.034 | Opioid delta receptor agonist | |||
| 0.019 | 0.01 | 0.019 | Nicotinic acid receptor 1 antagonist | |||
| 0.061 | 0.053 | 0.109 | Beta adrenoreceptor antagonist | 0.109 0.013 DBMET03097 | DBMET03097 | |
| 0.019 | 0.011 | 0.019 | Aminopeptidase A inhibitor | |||
| 0.031 | 0.023 | 0.031 | Glutamate (mGluR2) agonist | |||
| 0.027 | 0.019 | 0.027 | NMDA 2D receptor antagonist | |||
| 0.033 | 0.025 | 0.033 | RNA-directed RNA polymerase inhibitor | |||
| 0.05 | 0.043 | 0.09 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.09 0.013 DBMET03097 | DBMET03097 | |
| 0.079 | 0.072 | 0.079 | Transcription factor NF kappa B stimulant | |||
| 0.052 | 0.045 | 0.086 | Epithelial sodium channel blocker | 0.086 0.01 DBMET03097 | DBMET03097 | |
| 0.019 | 0.013 | 0.019 | Integrin alphaVbeta1 antagonist | |||
| 0.05 | 0.044 | 0.057 | Leukotriene B4 antagonist | 0.057 0.031 DBMET03097 | DBMET03097 | |
| 0.035 | 0.029 | 0.035 | Integrin alpha2 antagonist | |||
| 0.085 | 0.08 | 0.085 | Protease inhibitor | |||
| 0.059 | 0.054 | 0.059 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.026 | 0.021 | 0.026 | Baculoviral IAP repeat-containing protein 4 inhibitor | |||
| 0.022 | 0.017 | 0.027 | Prostaglandin F2 alpha agonist | 0.027 0.01 DBMET03097 | DBMET03097 | |
| 0.071 | 0.068 | 0.071 | Chymotrypsin inhibitor | |||
| 0.043 | 0.039 | 0.043 | GP IIb/IIIa receptor antagonist | |||
| 0.039 | 0.036 | 0.039 | Cathepsin F inhibitor | |||
| 0.025 | 0.022 | 0.025 | Integrin alpha2beta1 antagonist | |||
| 0.087 | 0.084 | 0.133 | GABA C receptor rho-1 antagonist | 0.133 0.03 DBMET03097 | DBMET03097 | |
| 0.031 | 0.028 | 0.031 | Carboxypeptidase B inhibitor | |||
| 0.078 | 0.076 | 0.105 | Estrogen-related receptor beta agonist | 0.105 0.019 DBMET03097 | DBMET03097 | |
| 0.016 | 0.014 | 0.016 | Telomerase stimulant | |||
| 0.138 | 0.136 | 0.138 | Catenin beta inhibitor | |||
| 0.057 | 0.055 | 0.057 | Caspase 9 inhibitor | |||
| 0.024 | 0.023 | 0.044 | Uridine phosphorylase inhibitor | 0.044 0.01 DBMET03097 | DBMET03097 | |
| 0.028 | 0.028 | 0.042 | Sirtuin 2 inhibitor | 0.042 0.016 DBMET03097 | DBMET03097 | |
| 0.173 | 0.173 | 0.226 | Lipoxygenase inhibitor | 0.226 0.117 DBMET03097 | DBMET03097 | |
| 0.05 | 0.053 | 0.065 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.065 0.035 DBMET03097 | DBMET03097 | |
| 0.132 | 0.136 | 0.143 | ATPase inhibitor | 0.143 0.113 DBMET03097 | DBMET03097 | |
| 0.036 | 0.041 | 0.038 | Sphingosine kinase 1 inhibitor | 0.038 0.035 DBMET03097 | DBMET03097 | |
| 0.022 | 0.029 | 0.029 | Somatostatin 5 antagonist | 0.029 0.024 DBMET03097 | DBMET03097 | |
| 0.015 | 0.023 | 0.027 | Estrogen-related receptor gamma agonist | 0.027 0.005 DBMET03097 | DBMET03097 | |
| 0.018 | 0.026 | 0.049 | Dopamine D1 agonist | 0.049 0.005 DBMET03097 | DBMET03097 | |
| 0.028 | 0.038 | 0.046 | Somatostatin 5 agonist | 0.046 0.014 DBMET03097 | DBMET03097 | |
| 0.018 | 0.029 | 0.026 | Beta 1 adrenoreceptor agonist | 0.026 0.011 DBMET03097 | DBMET03097 | |
| 0.061 | 0.072 | 0.063 | MDM2 inhibitor | 0.063 0.061 DBMET03097 | DBMET03097 | |
| 0.07 | 0.082 | 0.09 | MAP kinase kinase 7 inhibitor | 0.09 0.024 DBMET03097 | DBMET03097 | |
| 0.041 | 0.053 | 0.051 | Topoisomerase II beta inhibitor | 0.051 0.031 DBMET03097 | DBMET03097 | |
| 0.078 | 0.092 | 0.084 | Protein kinase C zeta inhibitor | 0.084 0.077 DBMET03097 | DBMET03097 | |
| 0.089 | 0.103 | 0.243 | MAO inhibitor | 0.243 0.029 DBMET03097 | DBMET03097 | |
| 0.041 | 0.055 | 0.051 | Acyl-CoA dehydrogenase inhibitor | 0.051 0.042 DBMET03097 | DBMET03097 | |
| 0.031 | 0.045 | 0.049 | Oxytocin agonist | 0.049 0.024 DBMET03097 | DBMET03097 | |
| 0.024 | 0.039 | 0.047 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.047 0.017 DBMET03097 | DBMET03097 | |
| 0.026 | 0.042 | 0.041 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.041 0.015 DBMET03097 | DBMET03097 | |
| 0.095 | 0.113 | 0.123 | Estrogen antagonist | 0.123 0.05 DBMET03097 | DBMET03097 | |
| 0.055 | 0.073 | 0.078 | Beta 3 adrenoreceptor antagonist | 0.078 0.024 DBMET03097 | DBMET03097 | |
| 0.037 | 0.059 | 0.115 | 5 Hydroxytryptamine 2 agonist | 0.115 0.007 DBMET03097 | DBMET03097 | |
| 0.075 | 0.096 | 0.1 | Urease inhibitor | 0.1 0.067 DBMET03097 | DBMET03097 | |
| 0.106 | 0.128 | 0.115 | Papain-like protease (SARS coronavirus) inhibitor | 0.115 0.095 DBMET03097 | DBMET03097 | |
| 0.071 | 0.094 | 0.089 | 5-Lipoxygenase inhibitor | 0.089 0.073 DBMET03097 | DBMET03097 | |
| 0.075 | 0.099 | 0.094 | UDP-glucose 4-epimerase inhibitor | 0.094 0.067 DBMET03097 | DBMET03097 | |
| 0.051 | 0.078 | 0.127 | Carbonic anhydrase VA inhibitor | 0.127 0.016 DBMET03097 | DBMET03097 | |
| 0.011 | 0.039 | 0.033 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.033 0.011 DBMET03097 | DBMET03097 | |
| 0.097 | 0.128 | 0.167 | Nav1.6 sodium channel blocker | 0.167 0.038 DBMET03097 | DBMET03097 | |
| 0.051 | 0.083 | 0.167 | Carbonic anhydrase XIII inhibitor | 0.167 0.019 DBMET03097 | DBMET03097 | |
| 0.033 | 0.065 | 0.064 | Carbonic anhydrase XIV inhibitor | 0.064 0.023 DBMET03097 | DBMET03097 | |
| 0.023 | 0.058 | 0.121 | Diamine oxidase inhibitor | 0.121 0.004 DBMET03097 | DBMET03097 | |
| 0.044 | 0.08 | 0.14 | Carbonic anhydrase V inhibitor | 0.14 0.017 DBMET03097 | DBMET03097 | |
| 0.05 | 0.086 | 0.096 | Na+ K+ transporting ATPase inhibitor | 0.096 0.035 DBMET03097 | DBMET03097 | |
| 0.026 | 0.064 | 0.037 | GABA uptake inhibitor | 0.037 0.032 DBMET03097 | DBMET03097 | |
| 0.019 | 0.058 | 0.035 | Cholesterol ester transfer protein antagonist | 0.035 0.017 DBMET03097 | DBMET03097 | |
| 0.036 | 0.075 | 0.087 | Beta 1 adrenoreceptor antagonist | 0.087 0.014 DBMET03097 | DBMET03097 | |
| 0.022 | 0.064 | 0.047 | Estradiol 17 beta-dehydrogenase inhibitor | 0.047 0.027 DBMET03097 | DBMET03097 | |
| 0.056 | 0.099 | 0.114 | Protein kinase A inhibitor | 0.114 0.037 DBMET03097 | DBMET03097 | |
| 0.02 | 0.064 | 0.031 | Estrogen-related receptor gamma antagonist | 0.031 0.014 DBMET03097 | DBMET03097 | |
| 0.072 | 0.118 | 0.108 | Estrogen receptor beta antagonist | 0.108 0.05 DBMET03097 | DBMET03097 | |
| 0.026 | 0.078 | 0.125 | Carbonic anhydrase VB inhibitor | 0.125 0.012 DBMET03097 | DBMET03097 | |
| 0.047 | 0.1 | 0.07 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.07 0.061 DBMET03097 | DBMET03097 | |
| 0.055 | 0.108 | 0.083 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.083 0.033 DBMET03097 | DBMET03097 | |
| 0.047 | 0.102 | 0.067 | Nav1.8 sodium channel blocker | 0.067 0.06 DBMET03097 | DBMET03097 | |
| 0.095 | 0.15 | 0.139 | Acetylcholine M1 receptor antagonist | 0.139 0.086 DBMET03097 | DBMET03097 | |
| 0.153 | 0.214 | 0.192 | Hypoxia-inducible factor 1 alpha inhibitor | 0.192 0.161 DBMET03097 | DBMET03097 | |
| 0.034 | 0.097 | 0.068 | NMDA 2B receptor antagonist | 0.068 0.026 DBMET03097 | DBMET03097 | |
| 0.057 | 0.121 | 0.091 | Estrogen receptor alpha antagonist | 0.091 0.034 DBMET03097 | DBMET03097 | |
| 0.181 | 0.245 | 0.309 | Calcium channel activator | 0.309 0.083 DBMET03097 | DBMET03097 | |
| 0.007 | 0.072 | 0.038 | Alpha 2a adrenoreceptor agonist | 0.038 0.004 DBMET03097 | DBMET03097 | |
| 0.202 | 0.27 | 0.235 | Calcium channel L-type activator | 0.235 0.222 DBMET03097 | DBMET03097 | |
| 0.015 | 0.085 | 0.043 | Phosphoglycerate kinase inhibitor | 0.043 0.017 DBMET03097 | DBMET03097 | |
| 0.023 | 0.094 | 0.046 | Geranyltranstransferase inhibitor | 0.046 0.027 DBMET03097 | DBMET03097 | |
| 0.079 | 0.157 | 0.161 | NADPH oxidase inhibitor | 0.161 0.048 DBMET03097 | DBMET03097 | |
| 0.046 | 0.128 | 0.063 | Histone deacetylase SIRT3 inhibitor | 0.063 0.04 DBMET03097 | DBMET03097 | |
| 0.074 | 0.159 | 0.108 | TRPA1 agonist | 0.108 0.075 DBMET03097 | DBMET03097 | |
| 0.064 | 0.151 | 0.104 | MAP kinase kinase 1 inhibitor | 0.104 0.051 DBMET03097 | DBMET03097 | |
| 0.014 | 0.103 | 0.063 | TRPM8 blocker | 0.063 0.011 DBMET03097 | DBMET03097 | |
| 0.037 | 0.128 | 0.07 | Protein kinase C beta inhibitor | 0.07 0.048 DBMET03097 | DBMET03097 | |
| 0.037 | 0.129 | 0.056 | I kappa B kinase 2 inhibitor | 0.056 0.055 DBMET03097 | DBMET03097 | |
| 0.025 | 0.117 | 0.084 | Adenylate cyclase 1 inhibitor | 0.084 0.006 DBMET03097 | DBMET03097 | |
| 0.063 | 0.156 | 0.109 | Acetylcholine muscarinic antagonist | 0.109 0.08 DBMET03097 | DBMET03097 | |
| 0.164 | 0.262 | 0.321 | GABA C receptor rho-3 antagonist | 0.321 0.103 DBMET03097 | DBMET03097 | |
| 0.029 | 0.133 | 0.114 | Dopamine agonist | 0.114 0.022 DBMET03097 | DBMET03097 | |
| 0.072 | 0.179 | 0.132 | Nav1.2 sodium channel blocker | 0.132 0.071 DBMET03097 | DBMET03097 | |
| 0.013 | 0.121 | 0.026 | Purinergic P2Y15 antagonist | 0.026 0.025 DBMET03097 | DBMET03097 | |
| 0.063 | 0.172 | 0.081 | CC chemokine 5 receptor agonist | 0.081 0.059 DBMET03097 | DBMET03097 | |
| 0.023 | 0.134 | 0.061 | Acetylcholine M3 receptor antagonist | 0.061 0.04 DBMET03097 | DBMET03097 | |
| 0.042 | 0.159 | 0.131 | Histamine N-methyltransferase inhibitor | 0.131 0.023 DBMET03097 | DBMET03097 | |
| 0.01 | 0.129 | 0.056 | 5 Hydroxytryptamine 2C agonist | 0.056 0.024 DBMET03097 | DBMET03097 | |
| 0.104 | 0.225 | 0.127 | MAP kinase kinase 4 inhibitor | 0.127 0.125 DBMET03097 | DBMET03097 | |
| 0.04 | 0.167 | 0.075 | I kappa B kinase inhibitor | 0.075 0.068 DBMET03097 | DBMET03097 | |
| 0.024 | 0.164 | 0.101 | Alpha 2 adrenoreceptor agonist | 0.101 0.014 DBMET03097 | DBMET03097 | |
| 0.051 | 0.192 | 0.104 | GABA receptor agonist | 0.104 0.072 DBMET03097 | DBMET03097 | |
| 0.027 | 0.17 | 0.194 | MAO B inhibitor | 0.194 0.026 DBMET03097 | DBMET03097 | |
| 0.013 | 0.16 | 0.057 | Alpha 1d adrenoreceptor agonist | 0.057 0.012 DBMET03097 | DBMET03097 | |
| 0.136 | 0.292 | 0.252 | 5 Hydroxytryptamine 3E antagonist | 0.252 0.015 DBMET03097 | DBMET03097 | |
| 0.018 | 0.184 | 0.048 | Histamine H1 receptor agonist | 0.048 0.021 DBMET03097 | DBMET03097 | |
| 0.04 | 0.208 | 0.1 | Sphingomyelinase inhibitor | 0.1 0.06 DBMET03097 | DBMET03097 | |
| 0.07 | 0.241 | 0.156 | Protein kinase (CK1) gamma 3 inhibitor | 0.156 0.083 DBMET03097 | DBMET03097 | |
| 0.058 | 0.236 | 0.118 | Nav1.5 sodium channel blocker | 0.118 0.058 DBMET03097 | DBMET03097 | |
| 0.086 | 0.264 | 0.132 | CF transmembrane conductance regulator agonist | 0.132 0.114 DBMET03097 | DBMET03097 | |
| 0.043 | 0.226 | 0.235 | 5 Hydroxytryptamine 3A agonist | 0.235 0.007 DBMET03097 | DBMET03097 | |
| 0.015 | 0.197 | 0.049 | Histamine H2 receptor agonist | 0.049 0.022 DBMET03097 | DBMET03097 | |
| 0.05 | 0.234 | 0.127 | Sodium channel (voltage-gated) blocker | 0.127 0.076 DBMET03097 | DBMET03097 | |
| 0.079 | 0.277 | 0.139 | Tumour necrosis factor antagonist | 0.139 0.115 DBMET03097 | DBMET03097 | |
| 0.023 | 0.23 | 0.128 | 5 Hydroxytryptamine 2C antagonist | 0.128 0.033 DBMET03097 | DBMET03097 | |
| 0.02 | 0.228 | 0.115 | Alpha adrenoreceptor agonist | 0.115 0.023 DBMET03097 | DBMET03097 | |
| 0.024 | 0.235 | 0.109 | CYP2A6 inhibitor | 0.109 0.032 DBMET03097 | DBMET03097 | |
| 0.011 | 0.224 | 0.037 | Melatonin 1 agonist | 0.037 0.018 DBMET03097 | DBMET03097 | |
| 0.054 | 0.272 | 0.173 | Toll-Like receptor antagonist | 0.173 0.042 DBMET03097 | DBMET03097 | |
| 0.02 | 0.24 | 0.061 | Dopamine D1 antagonist | 0.061 0.049 DBMET03097 | DBMET03097 | |
| 0.066 | 0.292 | 0.161 | MAP kinase kinase 2 inhibitor | 0.161 0.112 DBMET03097 | DBMET03097 | |
| 0.045 | 0.273 | 0.126 | Sodium channel blocker | 0.126 0.078 DBMET03097 | DBMET03097 | |
| 0.006 | 0.239 | 0.051 | Vascular adhesion protein 1 inhibitor | 0.051 0.015 DBMET03097 | DBMET03097 | |
| 0.09 | 0.326 | 0.19 | Death-associated protein kinase 2 inhibitor | 0.19 0.043 DBMET03097 | DBMET03097 | |
| 0.105 | 0.346 | 0.253 | 15-Lipoxygenase inhibitor | 0.253 0.162 DBMET03097 | DBMET03097 | |
| 0.007 | 0.263 | 0.029 | 5 Hydroxytryptamine 6 agonist | 0.029 0.02 DBMET03097 | DBMET03097 | |
| 0.013 | 0.271 | 0.117 | 5 Hydroxytryptamine 2A antagonist | 0.117 0.039 DBMET03097 | DBMET03097 | |
| 0.02 | 0.279 | 0.063 | 5 Hydroxytryptamine 7 agonist | 0.063 0.027 DBMET03097 | DBMET03097 | |
| 0.033 | 0.293 | 0.113 | 5 Hydroxytryptamine 2B antagonist | 0.113 0.068 DBMET03097 | DBMET03097 | |
| 0.172 | 0.445 | 0.27 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.27 0.256 DBMET03097 | DBMET03097 | |
| 0.022 | 0.301 | 0.143 | 5 Hydroxytryptamine 2 antagonist | 0.143 0.047 DBMET03097 | DBMET03097 | |
| 0.01 | 0.304 | 0.087 | 5 Hydroxytryptamine 1F antagonist | 0.087 0.038 DBMET03097 | DBMET03097 | |
| 0.008 | 0.307 | 0.032 | Melatonin agonist | 0.032 0.024 DBMET03097 | DBMET03097 | |
| 0.022 | 0.344 | 0.085 | 5 Hydroxytryptamine 5A antagonist | 0.085 0.021 DBMET03097 | DBMET03097 | |
| 0.019 | 0.347 | 0.075 | 5 Hydroxytryptamine 3 agonist | 0.075 0.031 DBMET03097 | DBMET03097 | |
| 0.005 | 0.347 | 0.041 | Dopamine D2 agonist | 0.041 0.033 DBMET03097 | DBMET03097 | |
| 0.01 | 0.362 | 0.054 | Alpha 1 adrenoreceptor agonist | 0.054 0.045 DBMET03097 | DBMET03097 | |
| 0.018 | 0.374 | 0.073 | 5 Hydroxytryptamine 5 antagonist | 0.073 0.024 DBMET03097 | DBMET03097 | |
| 0.054 | 0.417 | 0.282 | 5 Hydroxytryptamine 1E antagonist | 0.282 0.043 DBMET03097 | DBMET03097 | |
| 0.016 | 0.388 | 0.093 | Alpha 2a adrenoreceptor antagonist | 0.093 0.04 DBMET03097 | DBMET03097 | |
| 0.006 | 0.391 | 0.179 | 5 Hydroxytryptamine agonist | 0.179 0.017 DBMET03097 | DBMET03097 | |
| 0.012 | 0.428 | 0.083 | Pim-1 kinase inhibitor | 0.083 0.076 DBMET03097 | DBMET03097 | |
| 0.015 | 0.448 | 0.095 | Alpha 2 adrenoreceptor antagonist | 0.095 0.052 DBMET03097 | DBMET03097 | |
| 0.02 | 0.458 | 0.081 | Histamine H2 receptor antagonist | 0.081 0.063 DBMET03097 | DBMET03097 | |
| 0.014 | 0.461 | 0.084 | Adrenaline antagonist | 0.084 0.064 DBMET03097 | DBMET03097 | |
| 0.014 | 0.461 | 0.09 | Antiadrenergic | 0.09 0.063 DBMET03097 | DBMET03097 | |
| 0.036 | 0.491 | 0.144 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.144 0.117 DBMET03097 | DBMET03097 | |
| 0.016 | 0.482 | 0.149 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.149 0.066 DBMET03097 | DBMET03097 | |
| 0.004 | 0.737 | 0.098 | 5 Hydroxytryptamine 1 agonist | 0.098 0.021 DBMET03097 | DBMET03097 | |
| 0.007 | 0.841 | 0.1 | 5 Hydroxytryptamine 1B agonist | 0.1 0.007 DBMET03097 | DBMET03097 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |